During the last three months, 11 analysts shared their evaluations of 10x Genomics (NASDAQ:TXG), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results